0001051339-21-000001.txt : 20210318 0001051339-21-000001.hdr.sgml : 20210318 20210318151910 ACCESSION NUMBER: 0001051339-21-000001 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200720 FILED AS OF DATE: 20210318 DATE AS OF CHANGE: 20210318 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BENARROCH GEORGES CENTRAL INDEX KEY: 0001051339 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50390 FILM NUMBER: 21754123 MAIL ADDRESS: STREET 1: 49 AVENUE FOCH CITY: PARIS STATE: I0 ZIP: 75116 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Kyto Technology & Life Science, Inc. CENTRAL INDEX KEY: 0001164888 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 651086538 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 13050 PALOMA ROAD CITY: LOS ALTOS HILLS STATE: CA ZIP: 94022 BUSINESS PHONE: 650-204-7896 MAIL ADDRESS: STREET 1: 13050 PALOMA ROAD CITY: LOS ALTOS HILLS STATE: CA ZIP: 94022 FORMER COMPANY: FORMER CONFORMED NAME: KYTO BIOPHARMA INC DATE OF NAME CHANGE: 20030912 FORMER COMPANY: FORMER CONFORMED NAME: B TWELVE INC DATE OF NAME CHANGE: 20020111 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2020-07-20 0 0001164888 Kyto Technology & Life Science, Inc. KBPH 0001051339 BENARROCH GEORGES 49 AVENUE FOCH PARIS I0 75116 FRANCE 1 0 0 0 Non-qualified Stock Option (Right to Buy) 0.033 2020-07-20 4 A 0 50000 0 A 2020-07-20 2021-12-16 Common Shares 50000 200000 D 1 Stock option to purchase 50,000 common shares pursuant to Stock Option Plan granted to Georges Benarroch, Director on July 20, 2020. Immediate vesting. Georges Benarroch 2021-03-18